A research study investigating the effect of NNC0497-0040 in healthy participants, participants with overweight or obesity, and participants with type 1 diabetes with overweight or obesity.
Фаза 1 – тестване на безопасността при малка група хора
Заболявания:
Type I diabetes
Спонсор: Novo Nordisk A/S
Налично на:
БГ
Обобщение
Trial status: Authorised
Кой може да участва
Age group: 18-64 years
Gender: Female, Male
Target enrollment: 146 participants
БГ
EN